CORIS BIOCONCEPT

CORIS BIOCONCEPT has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €5.0m and a net result of -€391,631. Equity is shrinking by about 4.6% per year across the filed financial years. Its solvency ranks better than 67% of 45 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).